Krystal Biotech Shareholders Equity (Quarterly) Analysis

Krystal Biotech Inc (KRYS)

182.29 +4.19 (+2.35%) USD | NASDAQ | Nov 21, 16:00

182.39 +0.10 (+0.05%) After-Hours: 07:29

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
September 30, 2024	885.85M
June 30, 2024	838.89M
March 31, 2024	799.24M
December 31, 2023	778.64M
September 30, 2023	755.95M
June 30, 2023	653.11M
March 31, 2023	489.57M
December 31, 2022	522.23M
September 30, 2022	540.77M
June 30, 2022	559.18M
March 31, 2022	548.55M
December 31, 2021	593.58M
September 30, 2021	408.24M
June 30, 2021	418.54M
March 31, 2021	430.65M
December 31, 2020	292.08M

Date	Value
September 30, 2020	301.72M
June 30, 2020	309.70M
March 31, 2020	198.37M
December 31, 2019	202.91M
September 30, 2019	207.65M
June 30, 2019	198.29M
March 31, 2019	109.49M
December 31, 2018	113.23M
September 30, 2018	52.29M
June 30, 2018	45.27M
March 31, 2018	47.40M
December 31, 2017	49.47M
September 30, 2017	50.20M
June 30, 2017	3.393M
December 31, 2016	0.289M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

198.37M

Minimum

Mar 2020

885.85M

Maximum

Sep 2024

526.39M

Average

531.50M

Median

Shareholders Equity (Quarterly) Benchmarks

Bioventus Inc	148.74M
ADMA Biologics Inc	231.89M
Alnylam Pharmaceuticals Inc	32.35M
Amicus Therapeutics Inc	178.82M
Rhythm Pharmaceuticals Inc	11.22M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly)	982.32M
Total Liabilities (Quarterly)	96.47M
Current Ratio	7.966